Allergy Therapeutics PLC
LSE:AGY

Watchlist Manager
Allergy Therapeutics PLC Logo
Allergy Therapeutics PLC
LSE:AGY
Watchlist
Price: 10.7 GBX Market Closed
Market Cap: 657.1m GBX

Intrinsic Value

AGY price has not been updated for more than 3 weeks. This may indicate that the stock has been delisted.

The intrinsic value of one AGY stock under the Base Case scenario is hidden GBX. Compared to the current market price of 10.7 GBX, Allergy Therapeutics PLC is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

AGY Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Allergy Therapeutics PLC

Intrinsic Value History
Dive into the past to invest in the future

AGY looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether AGY usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about AGY?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is AGY valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Allergy Therapeutics PLC.

Explain Valuation
Compare AGY to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AGY?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Allergy Therapeutics PLC

Current Assets 42.2m
Cash & Short-Term Investments 21.7m
Receivables 8.6m
Other Current Assets 11.9m
Non-Current Assets 30.8m
Long-Term Investments 3m
PP&E 23.3m
Intangibles 4.5m
Current Liabilities 26.4m
Accounts Payable 14.2m
Other Current Liabilities 12.2m
Non-Current Liabilities 53.7m
Long-Term Debt 42.6m
Other Non-Current Liabilities 11.1m
Efficiency

Free Cash Flow Analysis
Allergy Therapeutics PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Allergy Therapeutics PLC

Revenue
55.7m GBP
Cost of Revenue
-25.6m GBP
Gross Profit
30.1m GBP
Operating Expenses
-58.4m GBP
Operating Income
-28.3m GBP
Other Expenses
-7.4m GBP
Net Income
-35.7m GBP
Fundamental Scores

AGY Profitability Score
Profitability Due Diligence

Allergy Therapeutics PLC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Declining Gross Margin
Declining Net Margin
hidden
Profitability
Score

Allergy Therapeutics PLC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

AGY Solvency Score
Solvency Due Diligence

Allergy Therapeutics PLC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
hidden
Solvency
Score

Allergy Therapeutics PLC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AGY Price Targets Summary
Allergy Therapeutics PLC

Wall Street analysts forecast AGY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AGY is 13.26 GBX with a low forecast of 13.13 GBX and a high forecast of 13.65 GBX.

Lowest
Price Target
13.13 GBX
23% Upside
Average
Price Target
13.26 GBX
24% Upside
Highest
Price Target
13.65 GBX
28% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Allergy Therapeutics PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for AGY is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one AGY stock?

The intrinsic value of one AGY stock under the Base Case scenario is hidden GBX.

Is AGY stock undervalued or overvalued?

Compared to the current market price of 10.7 GBX, Allergy Therapeutics PLC is hidden .

Back to Top